Taiwan Liposome Company, Ltd. (GTSM:4152) announced a private placement of no more than 30,000,000 shares on March 30, 2021. The shares will not be priced more than the simple average closing price of the common shares for 1, 3 or 5 trading days prior to the pricing date, or the simple average closing price of the common shares for 30 trading days prior to the pricing date. The shares issued will have a hold period of three years, post the closing. The transaction has been approved by the board of directors of the company. The transaction is subject to approval from the shareholders of the company in its annual shareholders meeting of 2021. The transaction will close within one year from the date of the shareholders’ resolution.